WAY

Waystar Holding Corp. Common Stock
NASDAQHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$4.36B
P/E Ratio
35.50
EPS
$0.64
Beta
0.07
52W High
$41.47
52W Low
$17.26
50-Day MA
$20.21
200-Day MA
$28.09
Dividend Yield
Profit Margin
10.90%
Forward P/E
14.01
PEG Ratio

About Waystar Holding Corp. Common Stock

Waystar Holding Corp. The company is headquartered in Lehi, Utah.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$1.16B
Gross Profit (TTM)$794.87M
EBITDA$413.98M
Operating Margin25.60%
Return on Equity3.57%
Return on Assets3.31%
Revenue/Share (TTM)$6.33
Book Value$20.54
Price-to-Book1.14
Price-to-Sales (TTM)3.77
EV/Revenue5.04
EV/EBITDA14.10
Quarterly Earnings Growth (YoY)37.50%
Quarterly Revenue Growth (YoY)22.40%
Shares Outstanding$191.81M
Float$139.70M
% Insiders1.48%
% Institutions110.58%

Historical Volatility

HV 10-Day
58.63%
HV 20-Day
57.09%
HV 30-Day
64.43%
HV 60-Day
69.43%
HV Rank
88.1%

Volatility is currently contracting

Analyst Ratings

Consensus ($33.57 target)
5
Strong Buy
17
Buy
1
Hold

Latest News

Waystar: Silently Taking Over Healthcare Billing

Waystar Holding Corp. is rated buy, with an 85% upside to a $37 price target, as current share price reflects temporary private equity (PE) selling pressure, not business fundamentals. Waystar's revenue grew 22% YoY, profit margins remain above 40%, and a $200M buyback offsets PE overhang; 23 of 24 analysts rate it Buy/Strong Buy. The Iodine acquisition and AI-powered AltitudeAI suite expand WAY's end-to-end billing solutions, driving new client wins and high retention in a $100B+ addressable market.

Seeking Alpha6/18/2026Positive
New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue

Healthcare leaders show unanimous interest in a single AI-powered platform connecting the mid-cycle to the final claim — yet 86% are still leaving revenue on the table LEHI, Utah and LOUISVILLE, Ky., June 9, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today released The State of the Mid-Revenue Cycle report.

PRNewsWire6/9/2026Neutral
Waystar to Speak at William Blair Conference

LEHI, Utah and LOUISVILLE, Ky., May 20, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will speak at the 46th Annual William Blair Growth Stock Conference on Tuesday, June 2, 2026, at 10:40 a.m.

PRNewsWire5/20/2026Neutral
Waystar: Revised Guidance Does Not Imply Demand Weakness

Waystar remains a buy as Q1 results confirm robust demand, with provider solutions leading and AI integration strengthening the platform story. WAY's Q1 revenue grew 22% y/y to $313.9M, with subscription revenue up 38% and net revenue retention at 111%, highlighting strong customer engagement. Patient payment solution headwinds stem from a faster shift to digital, seen as a near-term timing issue rather than a structural demand problem.

Seeking Alpha5/12/2026Neutral
Waystar Named to TIME100 Most Influential Companies

Wins TIME Impact in AI Award for purpose-built innovation in healthcare LEHI, Utah and LOUISVILLE, Ky., May 5, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it has been named to the TIME100 Most Influential Companies list and recognized as the TIME Impact in AI award winner for delivering proven outcomes across the healthcare revenue cycle.

PRNewsWire5/5/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026